Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Gamma-Aminobutyric acid Stories

2010-04-01 07:03:00

CORAL GABLES, Fla., April 1 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX), a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009. "In 2009, we transformed Catalyst into a multi-product company with compounds that have potential to address a variety of diseases...

2010-03-26 06:47:18

UCSF scientists report that they were able to prompt a new period of "plasticity," or capacity for change, in the neural circuitry of the visual cortex of juvenile mice. The approach, they say, might someday be used to create new periods of plasticity in the human brain that would allow for the repair of neural circuits following injury or disease. The strategy "“ which involved transplanting a specific type of immature neuron from embryonic mice into the visual cortex of young mice...

c45418f9f4810a637bf0977624df1f7e
2010-03-01 12:57:09

The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry. The study is co-authored by Drs. Andrea J. Levinson and Zafiris J. Daskalakis of the Centre for Addiction and Mental Health (CAMH). This study shows that compared to healthy individuals, people who have major depressive disorder have altered functions of the neurotransmitter GABA...

2010-02-22 07:03:00

CORAL GABLES, Fla., Feb. 22 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) will hold a conference call on Tuesday, February 23, 2010 to discuss its initial development plans for CPP-115. Patrick J. McEnany, Catalyst Pharmaceutical's Chief Executive Officer, will host the call. CPP-115 is a compound in a new class of GABA aminotransferase inhibitors in-licensed by Catalyst from Northwestern University. Catalyst is seeking to develop new prescription...

2010-02-17 07:03:00

CORAL GABLES, Fla., Feb. 17 /PRNewswire/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) announced today that it was selected by both the Scientific and Business Advisory Boards of the Epilepsy Therapy Project to present at the 2010 Epilepsy Pipeline Update Conference, an in-depth, two day forum to be held February 25-26, 2010, at the Hyatt Embarcadero Hotel in San Francisco. Charles W. Gorodetzky, M.D., Ph.D., Catalyst's Chief Medical Officer will present an overview of CPP-115,...

2009-12-28 17:11:09

 Scientists have created what appears to be a schizophrenic mouse by reducing the inhibition of brain cells involved in complex reasoning and decisions about appropriate social behavior. Findings by Medical College of Georgia scientists, published Dec. 28 in PNAS, elucidate the critical balance between excitation and inhibition of these cells that appears to go awry in schizophrenia. They also provide the first animal model for studying the disabling psychiatric disorder that affects...

99065b5b0086f25bf726ab0fb7b22a2e
2009-12-01 10:04:05

The research group of Professor Magdalena Götz of Helmholtz Zentrum Mnchen and Ludwig-Maximilians-Universität (LMU) Munich has made a significant advance in understanding regeneration processes in the brain. The researchers discovered progenitor cells which can form new glutamatergic neurons following injury to the cerebral cortex. Particularly in Alzheimer's disease, nerve cell degeneration plays a crucial role. In the future, new therapeutic options may possibly be derived from...

2009-10-26 14:26:00

NEW YORK, Oct. 26 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Ion Channel Modulator Pipelines: Targets and Agents in Development http://www.reportlinker.com/p0156556/Reportlinker-Adds-Ion-Channel-Modulator-Pipelines-Targets-and-Agents-in-Development.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire Ion channels represent a significant opportunity to address an underexploited class of...

2009-10-22 12:53:07

New study published in Biological Psychiatry There are increasingly precise molecular insights into ways that stress exposure leads to fear and through which fear extinction resolves these fear states. Extinction is generally regarded as new inhibitory learning, but where the inhibition originates from remains to be determined. Gamma-aminobutyric acid (GABA), the primary inhibitory chemical messenger in the brain, seems to be very important to these processes. A new article in Biological...

2009-10-09 09:15:33

Questions raised about use of antiseizure drug Researchers at the Stanford University School of Medicine have identified a key molecular player in guiding the formation of synapses "” the all-important connections between nerve cells "” in the brain. This discovery, based on experiments in cell culture and in mice, could advance scientists' understanding of how young children's brains develop as well as point to new approaches toward countering brain disorders in adults. The new...